EUI KIM: Open Payments
NPI 1063771202 · EMERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 7 payments from 6 companies in 2025. Trend: 2023 $78 · 2024 $124 · 2025 $274
Food & beverage: $216Honoraria: $58
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $125 |
| Becton, Dickinson and Company | 1 | $58 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Electromed, Inc. | 2 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Korlym, OPSUMIT, FASENRA, SMARTVEST, SHINGRIX.
Industry payments across NJ — which companies pay providers there.
